Janus Henderson Group’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25M Buy
+2,732,432
New +$19.4M 0.01% 590

Other funds holding EPRX

Janus Henderson Group's EPRX Position: Q3 2026 in Review

Janus Henderson Group opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q3 2026: 2,732,432 shares worth $25M. The stake represents 0.01% of the portfolio and ranks #590 among its holdings.

70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.

  • Janus Henderson Group held 2,732,432 shares of Eupraxia Pharmaceuticals worth $25M as of Q3 2026.
  • Eupraxia Pharmaceuticals was a new Janus Henderson Group position in Q3 2026.
  • Eupraxia Pharmaceuticals made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #590 holding.
  • 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.

Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.